Evofem Biosciences Inc
NASDAQ:EVFM 3:59:30 PM EDT
| Market Cap (Intraday) | 104.29M |
| Current PE | N/A |
| Forward PE | N/A |
| 2yr Forward PE | N/A |
| 10-Day MA | $0.73 |
| 50-Day MA | $0.77 |
| 200-Day MA | $1.63 |
Evofem Biosciences Inc Stock, NASDAQ:EVFM
12400 High Bluff Drive, Suite 600, San Diego, California 92130
United States of America
Phone: +1.858.550.1900
Number of Employees: 147
Description
Evofem Biosciences, Inc. is a commercial-stage biopharmaceutical company, which develops and commercializes innovative products to unmet needs in women's sexual and reproductive health. Its product includes Phexxi (lactic acid, citric acid and potassium bitartrate) a hormone-free vaginal gel and EVO100 an investigational drug, which is used for urogenital Chlamydia trachomatis and Neisseria gonorrhoeae infection in women. The company was founded in 2007 and is headquartered in San Diego, CA.